Figure 3
From: Mitigating prolonged QT interval in cancer nanodrug development for accelerated clinical translation

Stability analysis of hybrid nanoparticles at 4°C for 6 days. No significant change in particle size is observed for any batch.
From: Mitigating prolonged QT interval in cancer nanodrug development for accelerated clinical translation
Stability analysis of hybrid nanoparticles at 4°C for 6 days. No significant change in particle size is observed for any batch.